OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
Purpose
APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.
Condition
- Benign Prostatic Hyperplasia
Eligibility
- Eligible Ages
- All ages
- Eligible Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Patients treated with the Optilume BPH Catheter System in accordance with the Instructions for Use (IFU).
Exclusion Criteria
- Unwilling to abstain from sexual intercourse or use a condom for 30 days post-procedure and utilize a highly effective contraceptive for at least 12 months post-procedure 2. Presence of an artificial urinary sphincter, penile prosthesis, or stent(s) in the urethra or prostate 3. Confirmed or suspected malignancy of prostate or bladder. 4. Active urinary tract infection (UTI) 5. Anatomy (e.g., presence of false passage or size of meatus) is not suitable for treatment with the Optilume BPH Catheter System
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Case-Control
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Study Arm | This is the data collection study arm. There is no other arm in the study. |
|
Recruiting Locations
Tampa 4174757, Florida 4155751 33615
Kearney 5071348, Nebraska 5073708 68847
Las Vegas 5506956, Nevada 5509151 89144
Syosset 5140402, New York 5128638 11791
Austin 4671654, Texas 4736286 78705
Woodridge 4794585, Virginia 6254928 22191
More Details
- NCT ID
- NCT06560476
- Status
- Recruiting
- Sponsor
- Urotronic Inc.